---
title: "Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288566529.md"
description: "In the Phase 1/2 RESET-Myositis study, approximately 83% of patients diagnosed with dermatomyositis would have achieved the registrational primary endpoint. It was noted that all these patients were able to sustain their response without the need for immunomodulators for up to 1.5 years, as observed in the latest follow-up assessment."
datetime: "2026-06-03T11:01:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288566529.md)
  - [en](https://longbridge.com/en/news/288566529.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288566529.md)
generator: "portal-rs"
---

# Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress

In the Phase 1/2 RESET-Myositis study, approximately 83% of patients diagnosed with dermatomyositis would have achieved the registrational primary endpoint. It was noted that all these patients were able to sustain their response without the need for immunomodulators for up to 1.5 years, as observed in the latest follow-up assessment.

### Related Stocks

- [CABA.US](https://longbridge.com/en/quote/CABA.US.md)

## Related News & Research

- [HC Wainwright Reaffirms Buy Rating for Cabaletta Bio (NASDAQ:CABA)](https://longbridge.com/en/news/297682437.md)
- [10,754,701 Shares in Cabaletta Bio, Inc. $CABA Purchased by BlackRock Inc.](https://longbridge.com/en/news/297747973.md)
- [India’s richest man now wants to turn aging computers into AI-ready PCs](https://longbridge.com/en/news/297810053.md)
- [HP (HPQ) Could Be 30% Above Fair Value On Raised 2026 Guidance](https://longbridge.com/en/news/297462655.md)
- [PC Gold Seeks ASX Quotation for 71.4 Million New Shares](https://longbridge.com/en/news/297850818.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**